TRIM21 and glioblastoma: We detected an increase of CHK1 activation, as measured by CHK1 phosphorylation at Ser345, this increase was induced by temozolomide treatment in a TRIM21 knockdown glioblastoma U87 cell line (Supplementary Figure S2B).